Table 3 Laboratory findings of patients before PMX-DHP in anti-MDA-5 Ab positive and negative groups

140.3 (48.6–242.7)

251 (167–262.5)

0.024*

13 (11–17)

11 (9–15)

0.175

233.9 (177.0–309.6)

238.7 (191.8–361.2)

0.777

10,300 (3300–15,600)

13,200 (11100–19,400)

0.065

9527 (2670–13,603)

12,032 (7825–17,188)

0.258

510 (0–1310)

1774 (214–2775)

0.120

22.6 (9.4–31.6)

32.5 (29.7–40.7)

0.007*

466 (343–1104)

323 (171–462)

0.024*

0.64 (0.13–4.52)

2.17 (0.14–13)

0.888

1849 (403–4730)

1168 (390–2725)

0.258

71.3 (15–341)

166.1 (116.6–339.9)

0.090

1260.3(13–4362)

215.9 (145.3–701.3)

0.192

14.6 (2.7–37.4)

8.4 (3.6–30)

0.374